Compare Smith & Nephew plc (SNN) vs Sprott Uranium Miners ETF (URNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs Sprott Uranium Miners ETF — how do they compare? Smith & Nephew plc trades at $29.8 (market cap $12.54B), while Sprott Uranium Miners ETF trades at $55.51. The key difference: Smith & Nephew plc pays a 2.65% dividend while Sprott Uranium Miners ETF pays none, and Sprott Uranium Miners ETF is trading nearer its 52-week high, Smith & Nephew plc nearer its low. Which is the better fit depends on your goals.
| SNN | URNM | |
|---|---|---|
Market Cap | $12.54B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $38.70 | $83.99 |
52-Week Low | $28.73 | $44.14 |
Enterprise Value | $15.57B | — |
Dividend Yield | 2.65% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Smith & Nephew (SNN) trades at $29.76, down 1.06% with bearish technical signals. The company shows improving fundamentals with revenue growth from $5.8B to $6.2B and net income margin expanding to 10.08% in 2025. Recent Q2 2026 earnings beat expectations but the company lowered full-year revenue guidance from 6% to 4% growth due to U.S. Orthopaedics weakness.
While valuation multiples appear reasonable (P/E 20.41, EV/EBITDA 9.9), the stock faces headwinds from mixed earnings performance and cautious analyst sentiment. The primary investment case hinges on execution in robotics and wound care segments offsetting orthopedic challenges, with downside risk from continued U.S. market softness.
URNM trades at $55.50, up 1.65% today, with a bullish technical signal driven by moving averages. Recent news highlights strong nuclear sector tailwinds from AI power demand and government funding, though some articles question miner valuations. Support and resistance cluster tightly around $55-56, indicating potential volatility.
The outlook is positive given nuclear energy's role in AI infrastructure, but risks include uranium price volatility and concentrated miner exposure. Analyst sentiment is mixed, with debates over supply chain positioning versus pure uranium price leverage.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About Sprott Uranium Miners ETF
URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →
